1. Home
  2. CLW vs VYGR Comparison

CLW vs VYGR Comparison

Compare CLW & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clearwater Paper Corporation

CLW

Clearwater Paper Corporation

N/A

Current Price

$14.43

Market Cap

213.2M

ML Signal

N/A

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

N/A

Current Price

$1.70

Market Cap

193.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CLW
VYGR
Founded
1926
2013
Country
United States
United States
Employees
3710
N/A
Industry
Paper
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
213.2M
193.5M
IPO Year
2008
2015

Fundamental Metrics

Financial Performance
Metric
CLW
VYGR
Price
$14.43
$1.70
Analyst Decision
Hold
Strong Buy
Analyst Count
4
11
Target Price
★ $20.00
$14.22
AVG Volume (30 Days)
269.7K
★ 1.0M
Earning Date
10-26-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $1,555,400,000.00
$10,135,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.30
$164.37
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 12.42
N/A
52 Week Low
$11.73
$1.68
52 Week High
$23.59
$5.19

Technical Indicators

Market Signals
Indicator
CLW
VYGR
Relative Strength Index (RSI) 39.88 37.62
Support Level $12.21 $1.68
Resistance Level $14.56 $2.29
Average True Range (ATR) 0.97 0.13
MACD 0.14 0.03
Stochastic Oscillator 43.93 28.89

Price Performance

Historical Comparison
CLW
VYGR

About CLW Clearwater Paper Corporation

Clearwater Paper Corp is engaged in the manufacturing and supplier of Solid Bleached Sulfate (SBS) paperboard packaging products. The company products includes: SBS paperboard which is a premium paperboard grade that is frequently used to produce folding cartons, food service, commercial printing items. It generates maximum revenue from Pulp and Paperboard segment. Company operate in United States and have globalized access too. Geographically, it derives maximum revenue from the United States.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

Share on Social Networks: